April 15 (Reuters) - Kimberly-Clark KMB.O on Wednesday said its chief financial officer, Nelson Urdaneta, will become the finance chief of the combined company it will create after completing its $40-billion acquisition of Tylenol-maker Kenvue.
The deal, announced in November, is expected to close in the second half of 2026, pending regulatory approvals.
The new entity will operate with four business segments: North America, Asia Pacific Focus Markets, Europe-Middle East-Africa (EMEA), and Enterprise Markets, each led by regional presidents.
Russ Torres will serve as group president and chief operating officer, while other senior roles include chief growth officer, chief R&D officer and chief supply chain officer.
Kimberly-Clark said more than 30 teams working on the integration have identified opportunities to grow the business and reduce costs.
The acquisition of the former Johnson & Johnson JNJ.N unit, Kimberly-Clark's largest-ever deal, is set to create a global health and wellness giant with annual sales of roughly $32 billion, expanding the company's reach in consumer health and personal care.
Upon closing, Kimberly-Clark's CEO, Mike Hsu, is set to take over as the top boss and chairman of the combined company, it had said at the time of the deal.
(Reporting by Savyata Mishra in Bengaluru; Editing by Sahal Muhammed)
((Savyata.Mishra@thomsonreuters.com))